1354-1355 / 2437
Padovani et al., 2007
Medulloblastoma, retrospective Analysis,
253 Pat. (1975 – 2004)
EFS
5 years :
65%
10 years : 55%
OS
5 years :
72%
10 years : 55%
M0 : 5 J. 75%
M+ : 5 J: 57%
Dose PF </= 50Gy : 32%
Dose PF > 50 Gy : 76%
+ Chx.: 71%
- Chx. : 73%
Chemotherapy : no advantage
Medulloblastoma in Adults